Cargando…

Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial

BACKGROUND: Maladaptation can provoke important alterations in the arthrokinematics such as an internal rotation reduction in the dominant shoulder compared with the nondominant shoulder known as glenohumeral internal rotation deficit (GIRD). Though the number of studies investigating GIRD in athlet...

Descripción completa

Detalles Bibliográficos
Autores principales: Jácome-López, Rafael, Tejada-Gallego, Javier, Silberberg, José María, García-Sanz, Fernando, García-Muro San José, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519522/
https://www.ncbi.nlm.nih.gov/pubmed/37747030
http://dx.doi.org/10.1097/MD.0000000000035263
_version_ 1785109718375596032
author Jácome-López, Rafael
Tejada-Gallego, Javier
Silberberg, José María
García-Sanz, Fernando
García-Muro San José, Francisco
author_facet Jácome-López, Rafael
Tejada-Gallego, Javier
Silberberg, José María
García-Sanz, Fernando
García-Muro San José, Francisco
author_sort Jácome-López, Rafael
collection PubMed
description BACKGROUND: Maladaptation can provoke important alterations in the arthrokinematics such as an internal rotation reduction in the dominant shoulder compared with the nondominant shoulder known as glenohumeral internal rotation deficit (GIRD). Though the number of studies investigating GIRD in athletic population, there are not studies reporting the efficacy of the GIRD treatment in the nonathlete population, a kind of study required to improve our understanding of patient care with this pathology. This study aimed to describe the efficacy of the GIRD treatment in nonathlete population with shoulder pain. METHODS: An open single-arm trial with 35 patients was adopted for evaluating the efficacy of GIRD treatment in patients with shoulder pain. All patients with shoulder pain who attended the consultation, accepted, and agreed to participate in the study between October 2020 and March 2021 were included. A treatment sequence including joint manual therapy techniques and soft tissue release techniques was applied in the consultation. Then, patients were instructed to adapt the daily active biological stimulus at home. The IR before (IR(0)) and after (IR(1)) the treatment was considered the outcome measure. The GIRD was calculated as the difference between the IR of the non-painful shoulder and the IR of the painful shoulder before (GIRD(0)) and after treatment (GIRD(1)). A paired Student t test was used to compare the GIRD of each patient before and after the treatment. RESULTS: Treatment of the patients significantly increased the IR of the painful shoulder in all the patients (P-value < .0001) So, the mean IR(0) was 26.09 ± 14.46º (23.64–28.53), and after the treatment the mean IR(1) was 67.98 ± 15.03º (65.48–70.52). The mean difference after the treatment (IR(1)–IR(0)) was 41.89 ± 14.74º (39.4–44.39). The treatment also significantly reduced GIRD (P-value < .0001). So, the mean GIRD(0) was 42.95 ± 16.26º (40.2–45.7), and after the treatment the mean GIRD(1) was –1.05 ± 17.18º (–3.96 to 1.85). CONCLUSIONS: The treatment administrated in this study significantly increased the internal rotation of the treated and painful shoulder and reduced the GIRD from the first consultation. LEVEL OF EVIDENCE: Level 3.
format Online
Article
Text
id pubmed-10519522
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105195222023-09-26 Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial Jácome-López, Rafael Tejada-Gallego, Javier Silberberg, José María García-Sanz, Fernando García-Muro San José, Francisco Medicine (Baltimore) 6300 BACKGROUND: Maladaptation can provoke important alterations in the arthrokinematics such as an internal rotation reduction in the dominant shoulder compared with the nondominant shoulder known as glenohumeral internal rotation deficit (GIRD). Though the number of studies investigating GIRD in athletic population, there are not studies reporting the efficacy of the GIRD treatment in the nonathlete population, a kind of study required to improve our understanding of patient care with this pathology. This study aimed to describe the efficacy of the GIRD treatment in nonathlete population with shoulder pain. METHODS: An open single-arm trial with 35 patients was adopted for evaluating the efficacy of GIRD treatment in patients with shoulder pain. All patients with shoulder pain who attended the consultation, accepted, and agreed to participate in the study between October 2020 and March 2021 were included. A treatment sequence including joint manual therapy techniques and soft tissue release techniques was applied in the consultation. Then, patients were instructed to adapt the daily active biological stimulus at home. The IR before (IR(0)) and after (IR(1)) the treatment was considered the outcome measure. The GIRD was calculated as the difference between the IR of the non-painful shoulder and the IR of the painful shoulder before (GIRD(0)) and after treatment (GIRD(1)). A paired Student t test was used to compare the GIRD of each patient before and after the treatment. RESULTS: Treatment of the patients significantly increased the IR of the painful shoulder in all the patients (P-value < .0001) So, the mean IR(0) was 26.09 ± 14.46º (23.64–28.53), and after the treatment the mean IR(1) was 67.98 ± 15.03º (65.48–70.52). The mean difference after the treatment (IR(1)–IR(0)) was 41.89 ± 14.74º (39.4–44.39). The treatment also significantly reduced GIRD (P-value < .0001). So, the mean GIRD(0) was 42.95 ± 16.26º (40.2–45.7), and after the treatment the mean GIRD(1) was –1.05 ± 17.18º (–3.96 to 1.85). CONCLUSIONS: The treatment administrated in this study significantly increased the internal rotation of the treated and painful shoulder and reduced the GIRD from the first consultation. LEVEL OF EVIDENCE: Level 3. Lippincott Williams & Wilkins 2023-09-22 /pmc/articles/PMC10519522/ /pubmed/37747030 http://dx.doi.org/10.1097/MD.0000000000035263 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 6300
Jácome-López, Rafael
Tejada-Gallego, Javier
Silberberg, José María
García-Sanz, Fernando
García-Muro San José, Francisco
Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title_full Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title_fullStr Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title_full_unstemmed Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title_short Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial
title_sort treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: an open single-arm clinical trial
topic 6300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519522/
https://www.ncbi.nlm.nih.gov/pubmed/37747030
http://dx.doi.org/10.1097/MD.0000000000035263
work_keys_str_mv AT jacomelopezrafael treatmentofglenohumeralinternalrotationdeficitinthegeneralpopulationwithshoulderpainanopensinglearmclinicaltrial
AT tejadagallegojavier treatmentofglenohumeralinternalrotationdeficitinthegeneralpopulationwithshoulderpainanopensinglearmclinicaltrial
AT silberbergjosemaria treatmentofglenohumeralinternalrotationdeficitinthegeneralpopulationwithshoulderpainanopensinglearmclinicaltrial
AT garciasanzfernando treatmentofglenohumeralinternalrotationdeficitinthegeneralpopulationwithshoulderpainanopensinglearmclinicaltrial
AT garciamurosanjosefrancisco treatmentofglenohumeralinternalrotationdeficitinthegeneralpopulationwithshoulderpainanopensinglearmclinicaltrial